This study is accepting new patients by invitation only
Global Open-Label Extension Study of Del-desiran for the Treatment of DM1
Summary
- Eligibility
- for people ages 16 years and up (full criteria)
- Location
- at Los Angeles 5368361, California 5332921 and other locations
- Dates
- study startedstudy ends around
- Principal Investigator
- by Payam Soltanzadeh, MD

Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Payam Soltanzadeh, MD
HS Associate Clinical Professor, Neurology, Medicine. Authored (or co-authored) 17 research publications
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Avidity Biosciences, Inc.
- Links
- Sign up for this study
- ID
- NCT07008469
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 217 study participants
- Last Updated